Features
- Detection of 21 HPV genotypes in one single reaction
- CE-IVD marked and MNPA registered
- WHO HPV LabNet Proficiency Test validated (2011, 2013, 2015&2017)
- The ONLY HPV assay appointed by the Cervical Cancer Prevention Program in China (Over three million tests performed in 2019)
- High clinical sensitivity and clinical specificity: >95% (compared to FDA approved kit)
- Promising results compared to Roche’s Linear Array; with a better detection of HPV 52
- Include amplification control (IC) and hybridization control (Biotin) for monitoring of the entire experimental process
Specimens
- Cervical swab
- Liquid based cytology specimen (e.g. Thinprep, Surepath, Roche Female Swab Sample Kit, Hybribio Female Sample Collection Kit)
- Urine
- Exfoliated skin cells using sandpaper around genital area (Male)
